1 Result(s)

Article

Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-Analysis

Cabozantinib has recently been evaluated as a first-line treatment in advanced renal cell carcinoma (aRCC).

Elvira Schmidt, Johanna Lister, Monika Neumann, Witold Wiecek… in Targeted Oncology (2018)